{
 "drug": "Dobutamine Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "11/06/2017",
 "dayN": 3214,
 "cat": "Cardiovascular",
 "companies": [
  "Baxter Healthcare",
  "Hospira, Inc., a Pfizer Company",
  "Pfizer Inc.",
  "Hainan Poly Pharm. Co., Ltd."
 ],
 "reasons": [
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1077-02",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA020255"
    ],
    "brand_name": [
     "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "generic_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1077",
     "0338-1073",
     "0338-1075"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "309985",
     "309986",
     "309987"
    ],
    "spl_id": [
     "34c787c1-46f7-4264-951d-c88a34dca533"
    ],
    "spl_set_id": [
     "6b17b98b-e06d-42ed-925f-69aa2699dead"
    ],
    "package_ndc": [
     "0338-1073-02",
     "0338-1075-02",
     "0338-1077-02"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32)",
   "update_type": "Revised",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-3724-32",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "status": "Current",
   "dosage_form": "Injection"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-2344-01",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA074086"
    ],
    "brand_name": [
     "DOBUTAMINE"
    ],
    "generic_name": [
     "DOBUTAMINE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2344"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1812168"
    ],
    "spl_id": [
     "e71e9520-871b-479d-9652-1857fceca863",
     "f6a67673-07a7-44e4-b05c-1f7e63326f79"
    ],
    "spl_set_id": [
     "dc537761-d5f4-488d-24ab-b2bcd2b17b7a",
     "89becb0c-da60-4f43-0a98-29ff7a9eca58"
    ],
    "package_ndc": [
     "0409-2344-01",
     "0409-2344-62",
     "0409-2344-02",
     "0409-2344-68",
     "0409-2344-88"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32)",
   "update_type": "Revised",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-2346-32",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "status": "Current",
   "dosage_form": "Injection"
  },
  {
   "discontinued_date": "08/27/2025",
   "update_type": "New",
   "initial_posting_date": "08/27/2025",
   "package_ndc": "0409-2344-88",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA074086"
    ],
    "brand_name": [
     "DOBUTAMINE"
    ],
    "generic_name": [
     "DOBUTAMINE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2344"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1812168"
    ],
    "spl_id": [
     "e71e9520-871b-479d-9652-1857fceca863",
     "f6a67673-07a7-44e4-b05c-1f7e63326f79"
    ],
    "spl_set_id": [
     "dc537761-d5f4-488d-24ab-b2bcd2b17b7a",
     "89becb0c-da60-4f43-0a98-29ff7a9eca58"
    ],
    "package_ndc": [
     "0409-2344-01",
     "0409-2344-62",
     "0409-2344-02",
     "0409-2344-68",
     "0409-2344-88"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/27/2025",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32)",
   "update_type": "Revised",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-2347-32",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "status": "Current",
   "dosage_form": "Injection"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1075-02",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA020255"
    ],
    "brand_name": [
     "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "generic_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1075",
     "0338-1073",
     "0338-1077"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "309985",
     "309986",
     "309987"
    ],
    "spl_id": [
     "34c787c1-46f7-4264-951d-c88a34dca533"
    ],
    "spl_set_id": [
     "6b17b98b-e06d-42ed-925f-69aa2699dead"
    ],
    "package_ndc": [
     "0338-1073-02",
     "0338-1075-02",
     "0338-1077-02"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0338-1073-02",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA020255"
    ],
    "brand_name": [
     "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"
    ],
    "generic_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-1073",
     "0338-1075",
     "0338-1077"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "309985",
     "309986",
     "309987"
    ],
    "spl_id": [
     "34c787c1-46f7-4264-951d-c88a34dca533"
    ],
    "spl_set_id": [
     "6b17b98b-e06d-42ed-925f-69aa2699dead"
    ],
    "package_ndc": [
     "0338-1073-02",
     "0338-1075-02",
     "0338-1077-02"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-2344-02",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA074086"
    ],
    "brand_name": [
     "DOBUTAMINE"
    ],
    "generic_name": [
     "DOBUTAMINE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2344"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1812168"
    ],
    "spl_id": [
     "e71e9520-871b-479d-9652-1857fceca863",
     "f6a67673-07a7-44e4-b05c-1f7e63326f79"
    ],
    "spl_set_id": [
     "dc537761-d5f4-488d-24ab-b2bcd2b17b7a",
     "89becb0c-da60-4f43-0a98-29ff7a9eca58"
    ],
    "package_ndc": [
     "0409-2344-01",
     "0409-2344-62",
     "0409-2344-02",
     "0409-2344-68",
     "0409-2344-88"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "0409-2344-88",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA074086"
    ],
    "brand_name": [
     "DOBUTAMINE"
    ],
    "generic_name": [
     "DOBUTAMINE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2344"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1812168"
    ],
    "spl_id": [
     "e71e9520-871b-479d-9652-1857fceca863",
     "f6a67673-07a7-44e4-b05c-1f7e63326f79"
    ],
    "spl_set_id": [
     "dc537761-d5f4-488d-24ab-b2bcd2b17b7a",
     "89becb0c-da60-4f43-0a98-29ff7a9eca58"
    ],
    "package_ndc": [
     "0409-2344-01",
     "0409-2344-62",
     "0409-2344-02",
     "0409-2344-68",
     "0409-2344-88"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/06/2017",
   "package_ndc": "70436-203-80",
   "generic_name": "Dobutamine Hydrochloride Injection",
   "contact_info": "Slate Run Pharmaceuticals, LLC: 844-529-8988",
   "availability": "Available",
   "related_info": "Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988",
   "openfda": {
    "application_number": [
     "ANDA216131"
    ],
    "brand_name": [
     "DOBUTAMINE"
    ],
    "generic_name": [
     "DOBUTAMINE"
    ],
    "manufacturer_name": [
     "Slate Run Pharmaceuticals"
    ],
    "product_ndc": [
     "70436-203"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DOBUTAMINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1812168"
    ],
    "spl_id": [
     "49562559-8e19-fb8a-e063-6394a90a0966"
    ],
    "spl_set_id": [
     "ee09a55f-9992-48bb-b8d6-1184bd548536"
    ],
    "package_ndc": [
     "70436-203-80",
     "70436-203-82"
    ],
    "unii": [
     "0WR771DJXV"
    ]
   },
   "update_date": "05/08/2026",
   "therapeutic_category": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
   ],
   "dosage_form": "Injection",
   "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)",
   "company_name": "Hainan Poly Pharm. Co., Ltd.",
   "status": "Current"
  }
 ]
}